• Catalyst Pharmaceuticals (NASDAQ:CPRX) Upgraded by StockNews.com to "Strong-Buy" Rating

    Source: Buzz FX / 03 Jan 2025 22:31:14   America/Chicago


    Catalyst Pharmaceuticals (NASDAQ:CPRX) Upgraded by StockNews.com to "Strong-Buy" Rating Written by MarketBeat January 3, 2025 Share Link copied to clipboard. Catalyst Pharmaceuticals ( NASDAQ:CPRX - Get Free Report ) was upgraded by stock a
    Read more...
Share on,